This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 29 July 2024.

For the Commission

The President

Ursula VON DER LEYEN

( 1 ) OJ L 327, 11.12.2015, p. 1 . ELI: http://data.europa.eu/eli/reg/2015/2283/oj .

( 2 ) Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods ( OJ L 351, 30.12.2017, p. 72 ). ELI: http://data.europa.eu/eli/reg_impl/2017/2470/oj .

( 3 ) Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements ( OJ L 183, 12.7.2002, p. 51 ). ELI: http://data.europa.eu/eli/dir/2002/46/oj .

( 4 ) Kyowa Hakko Bio Co., Ltd, 2019, 2020, 2021, and 2022 (unpublished).

( 5 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 6 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 7 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 8 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 9 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 10 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 11 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 12 ) Kyowa Hakko Bio Co., Ltd, 2021, 2022, and 2023 (unpublished).

( 13 ) Kyowa Hakko Bio Co., Ltd, 2021 (unpublished).

( 14 ) Kyowa Hakko Bio Co., Ltd, 2021 and 2023 (unpublished).

( 15 ) Kyowa Hakko Bio Co., Ltd, 2020 (unpublished).

( 16 ) Kyowa Hakko Bio Co., Ltd, 2022 (unpublished).

( 17 ) Kyowa Hakko Bio Co., Ltd, 2019 (unpublished).

( 18 ) Kyowa Hakko Bio Co., Ltd, 2020 (unpublished).

( 19 ) Kyowa Hakko Bio Co., Ltd, 2021 and 2022 (unpublished).

( 20 ) EFSA Journal 2023;21(11):8333.

( 21 ) Address: Nakano Central Park South, Nakano 4-10-2, Nakano-ku, Tokyo 164-0001, Japan.

COMMISSION IMPLEMENTING REGULATION (EU) 2024/2036 of 29 July 2024 authorising the placing on the market of 2’-Fucosyllactose produced by a derivative strain of ANNEX